COMMUNIQUÉS West-GlobeNewswire

Microbix Announces Annual and Special Meeting Voting Results

27/03/2025 - 12:00

MISSISSAUGA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the “ Company ”), a life sciences innovator and exporter, announces the voting results from [...]

Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update

27/03/2025 - 12:00

First Analysis from Phase 1b Study of GT-02287 in Parkinson’s Disease Expected in Q2 2025 BETHESDA, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical- [...]

BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones

27/03/2025 - 12:00

Plinabulin Final Phase 3 Data Published in The Lancet Respiratory Medicine , Demonstrating Overall Survival Benefit in 2L/3L NSCLC EGFR Wild Type vs. Docetaxel Plinabulin Phase 2 Data Highlights Potential to Resensitize [...]

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

27/03/2025 - 11:30

Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary Perforations WAYNE, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical [...]

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

27/03/2025 - 11:00

STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]

Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy

27/03/2025 - 10:59

AURORA, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and other forms of chronic nerve discomfort. [...]

Zelluna ASA [ZLNA]: Share capital increase registered

27/03/2025 - 10:21

Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 26 March 2025 regarding the resolution of the board of directors of Zelluna ASA (the " Company ") to carry out a share capital [...]

LE QUÉBEC RATE UNE OCCASION DE GÉNÉRER DES REVENUS POUR LA SANTÉ PUBLIQUE

27/03/2025 - 10:00

MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- Avec déception, le Collectif Vital a constaté que le financement de la santé publique accuse un recul dans le budget 2025-2026 du ministre des Finances. La taxation des [...]

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer

27/03/2025 - 09:30

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad [...]

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer

27/03/2025 - 09:30

REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]

Pleco Therapeutics annonce un résultat positif de sa réunion de pré-IND avec la FDA pour la poursuite du développement du PTX-252 dans le cadre du traitement de la leucémie myéloïde aiguë

27/03/2025 - 08:15

NIMÈGE, Pays-Bas, 27 mars 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, société biopharmaceutique de phase clinique qui développe des thérapies innovantes pour les cancers difficiles à traiter, annonce un résultat [...]

CROSSJECT reports financial results for 2024

27/03/2025 - 07:30

Press Release CROSSJECT reports financial results for 2024 Continued satisfactory production of regulatory batches with a view to filing in Q2 2025. Recruitment of Tony Tipton as Chief Operating Officer USA. Visibility [...]

CROSSJECT publie ses résultats financiers pour 2024

27/03/2025 - 07:30

Communiqué de presse CROSSJECT publie ses résultats financiers pour 2024 Continuité dans la production satisfaisante de lots règlementaires en vue d’un dépôt de dossier en T2 2025. Recrutement de Tony Tipton aux Etats- [...]

Press release: Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025

27/03/2025 - 07:00

Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025 Ghent, Belgium – 27 March 2025 – Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical") , a [...]

Santhera proposes Dr. Melanie Rolli as new member of Board of Directors

27/03/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 27, 2025 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Melanie Rolli as an Independent Director at the upcoming Annual General [...]

Idorsia publishes its Annual Report 2024

27/03/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 27, 2025 Idorsia Ltd (SIX: IDIA) today announced the publication of the Annual Report 2024 – consisting of the Business Report, Governance Report [...]

Amaran Biotech Wins "Best CDMO in Automated Aseptic Filling"

27/03/2025 - 04:13

Honored at Taiwan Biopharma Excellence Awards 2025 TAIPEI, Taiwan, March 27, 2025 (GLOBE NEWSWIRE) -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was honored with the " [...]

Junshi Biosciences Announces Toripalimab’s Approval in Singapore

27/03/2025 - 02:00

SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

27/03/2025 - 01:24

PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]